GlassScriptPhysician profile
Donna Calvin
NPI 1164577920
$3,043.76
in general payments reported to CMS, 2019-2025
18 companies · $730 in 2025
The $730 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $419 · 2022: $374 · 2023: $758 · 2024: $763 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,251.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $549.63 | 2021-2024 | Evenity |
| Gilead Sciences, INC. | $450.65 | 2023-2025 | Epclusa, Livdelzi |
| Novo Nordisk INC | $283.27 | 2022-2024 | Wegovy |
| Abbvie INC. | $224.37 | 2023-2025 | |
| Horizon Therapeutics Plc | $206.85 | 2022-2023 | Krystexxa |
| Alexion Pharmaceuticals, INC. | $129.75 | 2023 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2025 | Spravato |
| Astrazeneca Pharmaceuticals LP | $121.21 | 2023 | Saphnelo |
| Antares Pharma, INC. | $114.84 | 2023 | Xyosted, Tlando, Nocdurna |
| Inspire Medical Systems, INC. | $110.52 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.90 | 2021 | |
| Exact Sciences Corporation | $107.09 | 2025 | The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $97.46 | 2023 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $93.88 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.57 | 2024 | Xifaxan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $91.26 | 2024 | Mounjaro |
| Allergan, INC. | $88.09 | 2021 | |
| Boston Scientific Corporation | $50.42 | 2025 | Apollo Esg System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Calvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.